Press Releases

May 07, 2021 9:00am EDT

Lexaria to Present at the Benzinga Global Small Cap Conference on May 13, 2021 at 3:50 p.m. ET

May 06, 2021 7:00am EDT

Lexaria Issues Successful Results from First 2021 Study, HYPER-A21-1

Apr 22, 2021 7:00am EDT

Lexaria Commences Human Clinical Hypertension Study

Apr 15, 2021 4:05pm EDT

Lexaria Appoints New Chief Financial Officer and Issues Consultant Warrants

Apr 14, 2021 7:00am EDT

Lexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network

Apr 06, 2021 7:05am EDT

Lexaria to Evaluate DehydraTECH(TM) in Multiple New Markets

Mar 24, 2021 7:00am EDT

Lexaria Technology Generates Positive Stability Testing for World-Class Ready-to-Drink CBD Beverages

Mar 22, 2021 7:00am EDT

Lexaria to Present at the Benzinga Biotech Small Cap Conference on March 24, 2021 at 9:45 AM ET

Mar 16, 2021 7:00am EDT

Lexaria's Antiviral Drug Evaluation Program Progressing

Mar 15, 2021 7:00am EDT

Rapid Progress in Hypertension Studies by Lexaria